MICHAEL KUO: Open Payments
NPI 1760922264 · TIFTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$798 in 31 payments from 15 companies in 2025. Trend: 2023 $141 · 2024 $893 · 2025 $798
Food & beverage: $798
| Company | Payments | Amount |
|---|---|---|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $196 |
| Sumitomo Pharma America, Inc. | 5 | $118 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $100 |
| Merck Sharp & Dohme LLC | 4 | $79 |
| ABIOMED | 3 | $73 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $42 |
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
| TOLMAR, INC. | 1 | $31 |
| BridgeBio Pharma, Inc. | 1 | $23 |
| Medtronic, Inc. | 1 | $22 |
Products named: LifeVest, JARDIANCE, VERQUVO, ORGOVYX, GEMTESA, Nubeqa, FARXIGA, JATENZO.
Industry payments across GA — which companies pay providers there.
